The DOI matches its Crossref record; 96 of the 97 references it cites were found in a registry or an index; 3 of the 197 sources its claims cite were checked for support.
Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases
Open accessAbstract
BACKGROUND: Although mental health concerns are known to occur commonly for those with inflammatory bowel diseases (IBD), the nature of this comorbid relationship has not been systematically reviewed to date. A review in 2007 identified 5 controversies regarding anxiety/depression rates and various comparators between and within IBD. We aimed to systematically analyze and critique the current evidence regarding this comorbidity, providing an update to the 5 controversies. METHODS: Ebscohost Medline, CINAHL, Embase, and PsychINFO were searched between 2005 and 2014 using systematic review methodology. Controlled quantitative studies examining either symptoms or diagnoses of anxiety and depression in IBD were included in the review, with study quality assessed using a scale developed a priori to evaluate observational research. RESULTS: (1) IBD versus healthy controls (pooled mean proportions) (n = 13 studies): anxiety 19.1% versus 9.6%, depression 21.2% versus 13.4%; (2) IBD inactive versus IBD active disease (n = 26): anxiety 28.2% versus 66.4%, depression 19.9% versus 34.7%; (3) ulcerative colitis versus Crohn's disease (n = 28): anxiety 31% versus 37%, depression 22% versus 24.4%; (4) IBD versus other chronic medical conditions (n = 17): anxiety 41.9% versus 48.2%, depression 14.5% versus 28.4%; (5) onset of anxiety/depression before or after IBD onset (n = 2): adults more likely to develop anxiety/depression before IBD onset, but a substantial proportion develops depression after onset; an increased risk for children of developing anxiety/depression after IBD onset. CONCLUSIONS: The high rates of anxiety and depression for those with IBD, particularly when disease is active, warrant a systemic approach to screening and treatment.
Overview
CoChat Summary
## TL;DR
This systematic review updated a 2007 review and found that anxiety and depression are more common in IBD than in healthy controls, are generally higher in active than inactive disease, and are only modestly higher in Crohn’s disease than ulcerative colitis. Evidence for whether anxiety/depression precede or follow IBD onset was limited to 2 studies and suggested anxiety often predates IBD in adults, while children with Crohn’s disease had increased post-diagnosis risk.
## Key findings
- Across the 5 controversies, the review included 66 unique studies; 4,985 studies were identified initially, 1,264 duplicates were removed, and 210 full papers were reviewed.
- IBD vs healthy/general population controls: pooled mean anxiety was 19.1% vs 9.6% and pooled mean depression was 21.2% vs 13.4% for IBD vs controls; in the narrative, 7 of 13 anxiety studies and 9 of 13 depression studies reported significantly higher rates/levels in IBD.
- Active vs inactive IBD: pooled mean anxiety was 66.4% in active disease vs 28.2% in inactive disease; pooled mean depression was 34.7% in active disease vs 19.9% in inactive disease. For anxiety, 11 of 15 studies with comparable data reported significantly higher anxiety in active vs inactive IBD; for depression, 12 of 17 reported significantly higher depression.
- Crohn’s disease vs ulcerative colitis: pooled mean anxiety was 37% in CD vs 31% in UC, and pooled mean depression was 24.4% in CD vs 22% in UC; only 3 anxiety studies and 2 depression studies found significant subtype differences, all favoring higher burden in CD.
- IBD vs other medically ill controls: pooled mean anxiety was 41.9% in IBD vs 48.2% in controls, and pooled mean depression was 14.5% in IBD vs 28.4% in controls; the paper notes mixed findings depending on the comparator group.
- Pre- vs post-IBD onset: only 2 studies addressed this. In adults, 70% with IBD and a lifetime anxiety/mood disorder had first anxiety episode 10+ years before IBD diagnosis, while 8% developed anxiety 2+ years after onset; in children, anxiety incidence was 1.81 vs 0.57 per 100 patient-years and depression incidence 2.69 vs 1.22 per 100 patient-years for IBD vs controls, and Crohn’s disease increased risk of anxiety (HR 2.28; 95% CI 1.65–3.17) and depression (HR 1.74; 95% CI 1.35–2.25).
## Methods
- Design: Systematic review, registered in PROSPERO (CRD42014014960) and conducted according to PRISMA.
- Data/sample: Searched Ebscohost Medline, CINAHL, Embase, and PsychINFO in November and December 2014 for peer-reviewed English-language quantitative studies published 2005–2014 on anxiety/depression in IBD; included controlled studies with adult or pediatric samples.
- Analysis: Two reviewers independently screened and extracted data; quality was appraised with a study-specific scale; the synthesis was narrative, with mean percentages and 95% CIs and weighted means where possible, because heterogeneity limited meta-analysis.
## Limitations
- The paper states that available studies were largely from Western Europe and North America, with few to none from Eastern Europe, South America, Asia, and Africa; it also states that it could not examine gender differences because virtually no studies reported male/female breakdowns.
- The paper states that most studies used symptom measures rather than clinical diagnoses, and that there was tremendous variability in measures and cutoffs, which limited cross-study comparability and meta-analysis.
- Evidence for timing relative to IBD onset was sparse: only 2 of 210 full-text-reviewed studies had applicable data, so conclusions about whether anxiety/depression precede or follow IBD are limited by the review’s own evidence base.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 1 Not valid · 88 Not checked · 85 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Overall, the lifetime prevalence of anxiety was 15.1% (± 3.7, 95% CI) versus 16.3% (± 2.6, 95% CI) for age and gender-matched controls (9).”
What the sources say
- Disputedcites [9] 9. Walker JR, Ediger JP, Graff LA, Greenfeld JM, Clara I, Lix L, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008 Aug;103(8):1989-97. Epub 2008/09/18. eng. sourceExperimental — accuracy not yet measured
Our copy reports a lifetime 'any anxiety disorder' rate of 31.6% in the Manitoba IBD cohort (Table 1/Table 6 rows, pp. 21 and 26), not 15.1%, and the only combined matched-control figure is 'any anxiety or mood disorder' 35.8% (IBD) vs 22.1% (matched CCHS 1.2 controls), OR 1.24, 95% CI 0.96–1.59 (Table 2, p. 22). The Abstract (p. 2) and Results (p. 9) state that direct matched-control comparisons were available for only three anxiety disorders — panic 8.0% vs 4.7%, social anxiety 6% vs 11%, agoraphobia without panic 1.1% vs 0.6% — so no overall lifetime anxiety comparison of 15.1% vs 16.3% exists in this paper, and the ±3.7 / ±2.6 margins appear nowhere. The numbers attributed to this source therefore run counter to the rates it actually reports. (LLM, conf=0.70)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For adult IBD participants, the rates of anxiety ranged from 15.1% (± 3.75, 95% CI) [all anxiety combined] based on diagnostic criteria in the population-based study by Walker (9), to 40% (±14.1, 95% CI), reported in a small case control study measuring anxiety symptoms for those with CD only (18).”
What the sources say
- Partly supportedcites [9] 9. Walker JR, Ediger JP, Graff LA, Greenfeld JM, Clara I, Lix L, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008 Aug;103(8):1989-97. Epub 2008/09/18. eng. sourceExperimental — accuracy not yet measured
Walker et al. (2008) is indeed the population-based, gold-standard diagnostic-interview study of anxiety and mood disorder prevalence in adult IBD (Cohort N=351; ABSTRACT p. 2, INTRODUCTION p. 4), so the design and basis the citing sentence attributes to it are correct. However, no passage of our copy reports a combined 'all anxiety' rate of 15.1% (±3.75, 95% CI). The aggregate figures our copy gives are 12-month 'Any anxiety or mood disorder' 13.6% in IBD vs 10.8% in matched controls and lifetime 35.8% vs 22.1% (Table 2, p. 22), plus disorder-specific rates (lifetime panic 8.0%, social anxiety 6.0%, GAD 13.4%, specific phobia 14.8%; RESULTS p. 9, ABSTRACT p. 2, Table 6 p. 26), and a lifetime anxiety-disorder subgroup of n=111 of the cohort (Table 3, p. 23). The specific number and its confidence interval attributed to this source are therefore not supported by our copy, even though the study's characterisation is. (LLM, conf=0.70)
- Not matchedcites [18] 18. Calvet X, Gallardo O, Coronas R, Casellas F, Montserrat A, Torrejón A, et al. Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn's disease. Inflammatory Bowel Diseases. 2006;12(8):692-6.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Nine found significantly higher rates and/or levels of depression in IBD participants than in healthy controls (n=3,517 IBD; n=12,212 controls) (9, 15, 16, 19-22, 24, 26).”
What the sources say
- Supportedcites [9] 9. Walker JR, Ediger JP, Graff LA, Greenfeld JM, Clara I, Lix L, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008 Aug;103(8):1989-97. Epub 2008/09/18. eng. source
The Abstract (p. 2) and Results (p. 9) of Walker et al. (2008) report a direct comparison of the Manitoba IBD cohort with a matched non-IBD community sample: lifetime major depressive disorder was significantly higher in IBD (27.2% vs 12.3%, OR 2.68, 95% CI 1.95-3.68), i.e. this study is one that found significantly higher depression rates in IBD participants than in a comparison group. The 12-month rate of MDD was elevated but not significant (OR 1.59, 95% CI 0.96-2.45), which is compatible with the citing sentence's 'rates and/or levels'; note the comparator here is a matched general-community sample rather than screened 'healthy' controls. (LLM, conf=0.82)
- Not checked yetcites [15] 15. Berrill JW, Gallacher J, Hood K, Green JT, Matthews SB, Campbell AK, et al. An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease. Neurogastroenterol Motil. 2013 Nov;25(11):918-e704. Epub 2013/08/29. eng. source
- Not checked yetcites [16] 16. Bessissow T, Van Keerberghen CA, Van Oudenhove L, Ferrante M, Vermeire S, Rutgeerts P, et al. Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controls. J Crohns Colitis. 2013 Dec 1;7(11):e580-7. Epub 2013/05/15. eng. source
- Not checked yetcites [19] 19. Cotton S, Kudel I, Roberts YH, Pallerla H, Tsevat J, Succop P, et al. Spiritual well-being and mental health outcomes in adolescents with or without inflammatory bowel disease. J Adolesc Health. 2009 May;44(5):485-92. Epub 2009/04/22. eng. source
- Not checked yetcites [20] 20. Goodhand JR, Wahed M, Mawdsley JE, Farmer AD, Aziz Q, Rampton DS. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis. 2012 Dec;18(12):2301-9. Epub 2012/02/24. eng. source
- Not checked yetcites [21] 21. Lerebours E, Gower-Rousseau C, Merle V, Brazier F, Debeugny S, Marti R, et al. Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study. Am J Gastroenterol. 2007 Jan;102(1):122-31. Epub 2006/11/15. eng. source
- Not checked yetcites [22] 22. Loftus Jr EV, Guérin A, Yu AP, Wu EQ, Yang M, Chao J, et al. Increased risks of developing anxiety and depression in young patients with crohn's disease. American Journal of Gastroenterology. 2011;106(9):1670-7. source
- Not checked yetcites [24] 24. Piche T, Ducrotte P, Sabate JM, Coffin B, Zerbib F, Dapoigny M, et al. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010 Jun;22(6):626-e174. Epub 2010/04/21. eng. source
- Not checked yetcites [26] 26. Van Langenberg DR, Gibson PR. Factors associated with physical and cognitive fatigue in patients with Crohn's disease: A cross-sectional and longitudinal study. Inflammatory Bowel Diseases. 2014;20(1):115-25. source
plainstates an associationn = 3,517- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“In children, a small cross-sectional study found low rates of clinically significant anxiety for both the IBD participants (2% ± 3.88, 95% CI) and the healthy non-IBD individuals (5% ± 6.59, 95% CI) (23).”
What the sources say
- Not checked yetcites [23] 23. Mackner LM, Crandall WV. Long-term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease. American Journal of Gastroenterology. 2005;100(6):1386-92.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In the four largest studies (n=839) which provided data on rates, 22% (± 2.8, 95% CI) of IBD patients with inactive IBD had clinically elevated anxiety (28, 29, 33, 39).”
What the sources say
- Not matchedcites [28] 28. Agostini A, Rizzello F, Ravegnani G, Gionchetti P, Tambasco R, Ercolani M, et al. Parental bonding and inflammatory bowel disease. Psychosomatics. 2010 Jan-Feb;51(1):14-21. Epub 2010/02/02. eng.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [29] 29. Bennebroek Evertsz F, Thijssens NAM, Stokkers PCF, Grootenhuis MA, Bockting CLH, Nieuwkerk PT, et al. Do Inflammatory Bowel Disease patients with anxiety and depressive symptoms receive the care they need? Journal of Crohn's and Colitis. 2012;6(1):68-76.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked yetcites [33] 33. Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis. 2006 Jan;12(1):38-46. Epub 2005/12/24. eng. source
- Not checked yetcites [39] 39. Kim ES, Cho KB, Park KS, Jang BI, Kim KO, Jeon SW, et al. Predictive factors of impaired quality of life in Korean patients with inactive inflammatory bowel disease: association with functional gastrointestinal disorders and mood disorders. J Clin Gastroenterol. 2013 Apr;47(4):e3844. Epub 2012/10/24. eng. source
plainn = 839- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
72 more claims
Create a free account to see all 176 claims and to verify the 160 references still open.
- It may state two separate claims as one. 61
- Probably not a substantial claim. 43
- The quote only partly states this claim. 4
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Up to 66% of individuals report symptoms during an active disease phase.5”
From Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): protocol for a feasibility trial of the ACTforIBD programme (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These links frequently translate into a high prevalence of anxiety and depression in people with IBD.5”
From Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): protocol for a feasibility trial of the ACTforIBD programme (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared with the general population, people diagnosed with inflammatory bowel disease (IBD) commonly experience symptoms of depression and anxiety (often collectively called distress) and poorer health-related quality of life (HRQoL).1,2”
From Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress. (2024) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“research findings highlight that individuals with IBD are also at increased risk of experiencing poor psychological wellbeing (Gao et al., 2021; Mikocka-Walus et al., 2016).”
From Moving Towards Acceptance and Values: A Qualitative Study of ACTforIBD Compared to IBD Psychoeducation (2024) · cites this paper as Mikocka-Walus et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“while these rates rise to 66% and 35% during IBD relapses.5”
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Gender differences in depression: Critical review
Piccinelli, M., & Wilkinson, G. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.6.486 · Cited by 2,376
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531
Mittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Miehsler, W., Beier, M., Tillinger, W., Gangl, A., & Moser, G. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000106907.24881.f2 · Cited by 532
Walker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., Rawsthorne, P., Miller, N., Rogala, L., McPhail, C. M., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01980.x · Cited by 437
Self-citationLatent structure of the Hospital Anxiety And Depression Scale: a 10-year systematic review
Cosco, T. D., Doyle, F., Ward, M., & McGee, H. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.06.008 · Cited by 417
The Hospital Anxiety and Depression Scale: A meta confirmatory factor analysis
Norton, S., Cosco, T., Doyle, F., Done, J., & Sacker, A. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.10.010 · Cited by 405
Sandanger, I., Moum, T., Ingebrigtsen, G., Dalgard, O. S., Sørensen, T., & Bruusgaard, D. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050064 · Cited by 327
Farrokhyar, F., Marshall, J. K., Easterbrook, B., & Irvine, J. E. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195391.49762.89 · Cited by 310 · cited 3×
“7, 95% CI).(18,27,28,30,33,34,37,40) In the 4 largest studies (n 1⁄4 839) that provided data on rates, 22% (62.”
BackgroundGraff, L. A., Walker, J. R., Lix, L., Clara, I., Rawsthorne, P., Rogala, L., Miller, N., Jakul, L., McPhail, C., Ediger, J., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.027 · Cited by 292
Self-citation
Research works printed but not linked: 5
- Agostini, 2010, Psychosomatics, 51, 14, 10.1016/s0033-3182(10)70654-x · DOI
- Iglesias-Rey, 2014, Inflamm Bowel Dis, 20, 92
- Brandi, 2009, Med Sci Monit, 15, PH101
- Ghia, 2008, J Clin Invest, 118, 2209
- Mikocka-Walus, 2009, 5, 48
Cited by
Barberio, B., Zamani, M., Black, C. J., Savarino, E. V., & Ford, A. C. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00014-5 · Cited by 758
Ulcerative Colitis in Adults: A Review
Gros, B., & Kaplan, G. G. (2023) · JAMA · doi:10.1001/jama.2023.15389 · Cited by 738
Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment
Bisgaard, T. H., Allin, K. H., Keefer, L., Ananthakrishnan, A. N., & Jess, T. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00634-6 · Cited by 572
Self-citationA comprehensive review and update on Crohn's disease
Gajendran, M., Loganathan, P., Catinella, A. P., & Hashash, J. G. (2018) · Disease-a-Month · doi:10.1016/j.disamonth.2017.07.001 · Cited by 550
Quality of life in inflammatory bowel disease: a systematic review and meta-analyses—part I
Knowles, S. R., Graff, L. A., Wilding, H., Hewitt, C., Keefer, L., & Mikocka-Walus, A. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx100 · Cited by 503
Self-citation
Metadata
- Authors
- Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L.
- Affiliations
- The Royal Melbourne Hospital (AU)
- Northwestern University (US)
- University of Manitoba (CA)
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03
- Volume
- 22
- Issue
- 3
- Pages
- 752-762
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2323558841
- Cited by
- 567
- References
- 97
- Citations by year
- 2026: 42 · 2025: 55 · 2024: 53 · 2023: 57 · 2022: 73 · 2021: 96 · 2020: 52 · 2019: 51 · 2018: 41 · 2017: 33 · 2016: 14
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion)
- Swinburne figshare (Swinburne University of Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- inflammatory bowel disease, anxiety
- MeSH terms
- Adult, Anxiety, Depression, Humans, Global Health, Inflammatory Bowel Diseases, Comorbidity, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases. https://app.cochat.ai/papers/10.1097/mib.0000000000000620
- The paper
- Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016). Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. https://doi.org/10.1097/mib.0000000000000620
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.